Finance Watch: Four Biotech VC Funds Raise $1.7bn Combined
New Venture Mega-Rounds Include Nuvalent’s $135m Series B
Private Company Edition: Perceptive/Xontogeny, Abingworth, Kizoo and Droia closed venture capital funds. New biopharma VC financings also include a $105m series C round for Elpiscience and $92m for newly launched Interline.
